Author

M. Cherkaoui

Primary ORCID profile (0009-0002-2691-2705 · 1 paper)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

M. CherkaouiiD1 paper · Long Island University

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

A. Kuemmel· 1 shared D. J. Price· 1 shared J. A. Simpson· 1 shared J. J. Moehrle· 1 shared J. S. McCarthy· 1 shared N. Gobeau· 1 shared S. Dini· 1 shared S. G. Zaloumis· 1 shared

Activity by Year

2020-2020 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

A. Kuemmel

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Seeking an optimal dosing regimen for OZ439-DSM265 combination therapy for treating uncomplicated falciparum malaria

S. Dini, S. G. Zaloumis, D. J. Price, N. Gobeau, A. Kuemmel, M. Cherkaoui, J. J. Moehrle, J. S. McCarthy, J. A. Simpson

This study uses a mathematical model to determine an optimal dosing regimen for OZ439-DSM265 combination therapy to treat uncomplicated falciparum malaria, predicting a regimen that cures 90% of patients within 42 days.

bioRxiv · Nov 2, 2020Pharmacology & Toxicology